**Question:** Which of the following is most active against both dormant & non-dormant bacilli -

A. Streptomycin
B. Ethambutol
C. Amikacin
D. Kanamycin

**Core Concept:** The question is testing our understanding of antibiotics that are effective against both active and resting (dormant) bacteria, particularly Mycobacterium tuberculosis, the causative agent of Tuberculosis (TB). Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis, which can enter a dormant state called latency, making it more resistant to standard antibiotics.

**Why the Correct Answer is Right:**

**Correct Answer: D. Kanamycin**

Kanamycin is a broad-spectrum aminoglycoside antibiotic that works by inhibiting protein synthesis in bacteria. In the context of TB, its activity against both active and dormant bacilli is crucial. Aminoglycosides, like kanamycin, are known to have bactericidal activity against actively growing bacteria, as well as bacteriostatic activity against non-dividing bacilli. This dual action makes kanamycin an effective choice against M. tuberculosis, which can exist in both active and dormant forms.

**Why Each Wrong Option is Incorrect:**

**Option A (Streptomycin):** Although streptomycin is also an aminoglycoside antibiotic, its activity against dormant bacilli is limited. It is less effective against non-dividing bacteria due to its inability to penetrate the cell wall of these bacteria.

**Option B (Ethambutol):** Ethambutol is an inhibitor of mycolic acid synthesis in the bacterial cell wall, which primarily targets actively growing bacteria. Its effectiveness against dormant bacilli is relatively low.

**Option C (Amikacin):** Amikacin is also an aminoglycoside antibiotic, similar to kanamycin. However, its penetration into non-dividing bacteria is less efficient compared to kanamycin, limiting its effectiveness against dormant M. tuberculosis bacilli.

**Core Concept:** Understanding the pharmacology of antibiotics, particularly aminoglycosides like kanamycin, is essential for effectively treating infections caused by bacteria that can exist in both active and dormant forms, like M. tuberculosis.

**Why Each Wrong Option is Incorrect:**

For each wrong option, explain the reason behind its limited effectiveness against dormant bacilli, focusing on the pharmacology of the antibiotic and its interaction with bacteria.

**Why Kanamycin is Right:** Kanamycin demonstrates the ability to penetrate both actively dividing and non-dividing bacteria, making it effective against M. tuberculosis in both active and dormant forms. This dual action contributes to its usefulness in TB treatment regimens.

**Clinical Pearls:**

1. Aminoglycosides, such as kanamycin, are effective against actively dividing bacteria by binding to the 30S ribosomal subunit and inhibiting protein synthesis.
2. Beyond actively dividing bacteria, aminoglycosides can also permeabil